Janne Uldal Rahbek

CMC Project Manager
Ophthalmology
MC2 Therapeutics
Denmark

Business Expert Ophthalmology
Biography

Janne Uldal Rahbek joined MC2 Therapeutics in March 2017. Janne has a strong CMC and regulatory affairs biotech record both from development, approval and life cycle management, e.g. from ALK-Abelló A/S, Genmab A/S and Novartis Vaccine. Janne comes from a manager position at Novartis/GSK Vaccine where she has orchestrated the approval and CMC life cycle management challenges of the meningitis vaccine portfolio. Janne holds masters in Pharmacy and Human Biology from the University of Copenhagen.

Research Intrest

 Ophthalmology